儿童无意伤害预防的发展考虑因素
Maneesha Agarwal1, Terri D McFadden2, David C Schwebel3
1Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, 49 Jesse Hill Jr Drive, Atlanta, GA 30303, USA; Department of Emergency Medicine, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA, USA.
Pediatric clinics of North America
|November 5, 2025
概括
童年受伤是导致死亡的主要原因,随着儿童的发展,风险会发生变化. 本综述涵盖了所有儿童的特定年龄受伤风险和预防措施,包括那些有发育差异的儿童.
科学领域:
- 儿科医学 儿科医学 儿科医学
- 发展心理学是发展心理学.
- 公共卫生 公共卫生
背景情况:
- 伤害是儿童和青少年死亡的主要原因.
- 由于发育变化,受伤风险是动态的,在整个童年和青春期内不断演变.
- 了解这些发育转变对于有效预防伤害至关重要.
研究的目的:
- 审查与儿童发育不同阶段相关的受伤风险因素和预防策略.
- 为临床医生提供有关儿童伤害预防的咨询家庭的信息.
- 针对有发育差异的儿童的特殊伤害考虑.
主要方法:
- 对影响受伤风险的发育变化的文献综述.
- 年龄特定的受伤风险因素的综合分析.
- 确定量身定制的预防策略.
- 包括对患有自闭症谱系障碍,注意力缺陷/多动症障碍和感官障碍的儿童的考虑.
主要成果:
- 身体,认知,运动和社会领域的发育变化显著影响受伤易感性.
- 预防策略必须适应孩子不断变化的发育阶段.
- 具有发育差异的儿童可能面临独特或放大伤害风险,需要专门的方法.
结论:
- 有效的儿科伤害预防需要一个发展的角度.
- 临床医生在教育家庭关于适合年龄的风险和安全措施方面发挥着至关重要的作用.
- 定制策略对于保护有发育差异的儿童免受伤害至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
201
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
239
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
239
Pharmacokinetics in Pediatric Patients: Drug Metabolism
185
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
Drug Dosing: Infants and Children
241
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
241
Healthcare Associated Infections II: Preventive Measures
3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K


